NO20060395L - Antigenholdig dyrevaksine - Google Patents
Antigenholdig dyrevaksineInfo
- Publication number
- NO20060395L NO20060395L NO20060395A NO20060395A NO20060395L NO 20060395 L NO20060395 L NO 20060395L NO 20060395 A NO20060395 A NO 20060395A NO 20060395 A NO20060395 A NO 20060395A NO 20060395 L NO20060395 L NO 20060395L
- Authority
- NO
- Norway
- Prior art keywords
- antigen
- moiety
- animal
- containing animal
- animal vaccine
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 6
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000002255 vaccination Methods 0.000 abstract 2
- 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0318247.4A GB0318247D0 (en) | 2003-08-05 | 2003-08-05 | Antigen delivery system |
| PCT/GB2004/003386 WO2005014040A2 (en) | 2003-08-05 | 2004-08-05 | Antigen delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060395L true NO20060395L (no) | 2006-03-06 |
Family
ID=27839615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060395A NO20060395L (no) | 2003-08-05 | 2006-01-25 | Antigenholdig dyrevaksine |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20070142312A1 (de) |
| EP (1) | EP1667715B1 (de) |
| JP (1) | JP2007501009A (de) |
| KR (1) | KR20060125675A (de) |
| CN (1) | CN1867356A (de) |
| AT (1) | ATE443525T1 (de) |
| AU (1) | AU2004262980B2 (de) |
| BR (1) | BRPI0413290A (de) |
| CA (1) | CA2533550A1 (de) |
| DE (1) | DE602004023311D1 (de) |
| ES (1) | ES2356344T3 (de) |
| GB (1) | GB0318247D0 (de) |
| MX (1) | MXPA06001416A (de) |
| NO (1) | NO20060395L (de) |
| NZ (1) | NZ544965A (de) |
| RU (1) | RU2006106738A (de) |
| WO (1) | WO2005014040A2 (de) |
| ZA (1) | ZA200601024B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100087344A (ko) | 2007-10-29 | 2010-08-04 | 버지니아 테크 인터렉추얼 프라퍼티스, 인크. | 돼지 ＤＣ-ＳＩＧＮ, ＩＣＡＭ－３ 및 ＬＳＥＣｔｉｎ 및 이의 용도 |
| JP2012523379A (ja) * | 2009-04-09 | 2012-10-04 | ザ ユニバーシティー オブ メルボルン | 免疫原性組成物およびその使用 |
| US10193304B2 (en) * | 2016-07-01 | 2019-01-29 | Intel Corporation | Failsafe pulsed laser driver |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020187131A1 (en) * | 1995-01-31 | 2002-12-12 | Daniel Hawiger | Enhanced antigen delivery and modulation of the immune response therefrom |
| EP0808366A1 (de) * | 1995-01-31 | 1997-11-26 | The Rockefeller University | Identifizierung von dec-205, (dentritischen und epithelzellen, 205 kda), rezeptor mit c-typ lektin regionen, dafür kodierende nukleinsäure und verwendungen davon |
| US6235280B1 (en) * | 1996-04-12 | 2001-05-22 | Malaya Chatterjee | Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1 |
| US6391567B1 (en) * | 2000-03-02 | 2002-05-21 | New York University | Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
| US7560534B2 (en) * | 2000-05-08 | 2009-07-14 | Celldex Research Corporation | Molecular conjugates comprising human monoclonal antibodies to dendritic cells |
| US6461616B1 (en) * | 2000-09-09 | 2002-10-08 | Akzo Nobel Nv | EIAV p26 deletion vaccine and diagnostic |
| WO2003084467A2 (en) * | 2002-04-01 | 2003-10-16 | Euro-Celtique S.A. | Epitope constructs comprising antigen presenting cell targeting mechanisms |
| WO2004092195A2 (en) * | 2003-04-09 | 2004-10-28 | Administrators Of The Tulane Educational Fund | Dendritic cell binding proteins and uses thereof |
-
2003
- 2003-08-05 GB GBGB0318247.4A patent/GB0318247D0/en not_active Ceased
-
2004
- 2004-08-05 ES ES04743671T patent/ES2356344T3/es not_active Expired - Lifetime
- 2004-08-05 WO PCT/GB2004/003386 patent/WO2005014040A2/en not_active Ceased
- 2004-08-05 CA CA002533550A patent/CA2533550A1/en not_active Abandoned
- 2004-08-05 CN CNA2004800291355A patent/CN1867356A/zh active Pending
- 2004-08-05 NZ NZ544965A patent/NZ544965A/xx unknown
- 2004-08-05 AU AU2004262980A patent/AU2004262980B2/en not_active Ceased
- 2004-08-05 JP JP2006522404A patent/JP2007501009A/ja active Pending
- 2004-08-05 KR KR1020067001753A patent/KR20060125675A/ko not_active Withdrawn
- 2004-08-05 BR BRPI0413290-4A patent/BRPI0413290A/pt not_active Application Discontinuation
- 2004-08-05 AT AT04743671T patent/ATE443525T1/de not_active IP Right Cessation
- 2004-08-05 US US10/566,866 patent/US20070142312A1/en not_active Abandoned
- 2004-08-05 DE DE602004023311T patent/DE602004023311D1/de not_active Expired - Lifetime
- 2004-08-05 EP EP04743671A patent/EP1667715B1/de not_active Expired - Lifetime
- 2004-08-05 RU RU2006106738/15A patent/RU2006106738A/ru not_active Application Discontinuation
- 2004-08-05 MX MXPA06001416A patent/MXPA06001416A/es active IP Right Grant
-
2006
- 2006-01-25 NO NO20060395A patent/NO20060395L/no not_active Application Discontinuation
- 2006-02-03 ZA ZA200601024A patent/ZA200601024B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1867356A (zh) | 2006-11-22 |
| CA2533550A1 (en) | 2005-02-17 |
| EP1667715B1 (de) | 2009-09-23 |
| EP1667715A2 (de) | 2006-06-14 |
| BRPI0413290A (pt) | 2006-10-10 |
| WO2005014040A3 (en) | 2005-04-28 |
| GB0318247D0 (en) | 2003-09-10 |
| ES2356344T3 (es) | 2011-04-07 |
| US20070142312A1 (en) | 2007-06-21 |
| JP2007501009A (ja) | 2007-01-25 |
| AU2004262980A1 (en) | 2005-02-17 |
| ZA200601024B (en) | 2008-07-30 |
| KR20060125675A (ko) | 2006-12-06 |
| DE602004023311D1 (de) | 2009-11-05 |
| NZ544965A (en) | 2009-02-28 |
| MXPA06001416A (es) | 2006-05-15 |
| RU2006106738A (ru) | 2006-07-27 |
| AU2004262980B2 (en) | 2010-04-22 |
| ATE443525T1 (de) | 2009-10-15 |
| WO2005014040A2 (en) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
| CY1119650T1 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| CY1113546T1 (el) | Μικρορευστοποιημενα γαλακτωματα ελαιου σε νερο και συνθεσεις εμβολιων | |
| CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
| ATE426412T1 (de) | Adjuvante influenza-vakzine | |
| EA200601603A1 (ru) | Миметические антитела glp-1 человека, композиции, способы и применения | |
| NO20054608L (no) | Influensavirusvaksine | |
| EA200501524A1 (ru) | Антитела против амилоида, композиции, способы и применения | |
| NO20076563L (no) | Anti- MCP-1 antistoffer, sammensetninger og anvendelser | |
| ATE461710T1 (de) | Nipah-virus-impfstoffe | |
| CY1113104T1 (el) | Νεα σκευασματα εμβολιων | |
| AR059648A1 (es) | Antigenos vacunales quimericos contra el virus de la peste porcina clasica | |
| SG163598A1 (en) | Lawsonia vaccine and methods of use thereof | |
| CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
| WO2007140244A3 (en) | Vaccination of young animals against lawsonia intracellularis infections | |
| NO20055857L (no) | Materialer og fremgangsmater til immunisering mot FIV-infeksjon | |
| ATE443525T1 (de) | Antigen-zufuhrsystem | |
| DE60239753D1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
| WO2006062637A3 (en) | Influenza vaccination | |
| EP1543838A4 (de) | Vakzine gegen infektiöse katzen-peritonitis | |
| ATE495758T1 (de) | Virulentes systemisches felines calicivirus | |
| AR057225A1 (es) | Vacunas marcadas contra el virus de la diarrea virica bovina | |
| GB2429711A (en) | Heart and skeletal muscle inflammation (HSMI) virus | |
| MX2009000717A (es) | Composicion para vacuna y metodo para inmunizacion. | |
| BRPI0318114B8 (pt) | Vacinação ou imunização utilizando um regime de iniciação-reforço |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |